Page last updated: 2024-12-07

erythrose

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Erythrose is a tetrose aldose monosaccharide with the chemical formula C4H8O4. It is a naturally occurring sugar found in small amounts in various plants and bacteria. Erythrose is not commonly found in its free form but is often a precursor in the synthesis of other important molecules, such as vitamin B6. Erythrose is involved in the pentose phosphate pathway, which is a crucial metabolic pathway for the production of NADPH and the biosynthesis of nucleic acids. Erythrose also plays a role in the synthesis of shikimic acid, a precursor to aromatic amino acids and other secondary metabolites. Erythrose is an important intermediate in the synthesis of several biologically active compounds, including the antibiotic erythromycin and the antifungal agent griseofulvin. Due to its role in various metabolic pathways and its potential for drug development, erythrose has been the subject of numerous research studies. Researchers have investigated its synthesis, its effects on various biological processes, and its potential therapeutic applications. Erythrose has shown promise as a potential treatment for cancer and other diseases, and ongoing research aims to further explore its therapeutic properties.'

D-erythrose : The D-enantiomer of erythrose. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID94176
CHEBI ID27904
SCHEMBL ID42624
MeSH IDM0198285

Synonyms (36)

Synonym
756ez12ft6 ,
unii-756ez12ft6
(2r,3r)-2,3,4-trihydroxybutanal
CHEBI:27904
d-erythro-tetrose
erythrose ,
butanal, 2,3,4-trihydroxy-, (r*,r*)-
583-50-6
d-erythrose
1758-51-6
B1552B3E-262B-4CEF-A0A9-79C534BCEE4E
d-(-)-erythrose
A831843
einecs 209-505-2
unii-x3ei0we8q4
x3ei0we8q4 ,
AKOS016011079
butanal, 2,3,4-trihydroxy-, (2r,3r)-
erythrose, d-
d-erythrose [mi]
210230-59-4
SCHEMBL42624
(+/-)-erythrose
erythrose, dl-
butanal, 2,3,4-trihydroxy-, (2r,3r)-rel-
dl-erythrose
butanal,2,3,4-trihydroxy-, (2r,3r)-
d(-)-erythrose
Q423225
DTXSID201017424
d-erythrose (ca. 70% in water)
T72661
DTXSID601318240
CS-0066906
rel-(2r,3r)-2,3,4-trihydroxybutanal
HY-116956

Research Excerpts

Overview

D-Erythrose is a C4 monosaccharide with a biological and potential astrobiological relevance.

ExcerptReferenceRelevance
"D-Erythrose is a C4 monosaccharide with a biological and potential astrobiological relevance. "( Tautomers of Gas-Phase Erythrose and Their Interconversion Reactions: Insights from High-Level ab Initio Study.
Moc, J; Szczepaniak, M, 2015
)
1.45

Toxicity

ExcerptReferenceRelevance
" Three carbon sugars, such as glyceraldehyde and dihydroxy acetone, and the two carbon sugar glycolaldehyde, were similarly toxic in an O-2-dependent manner."( Superoxide dependence of the toxicity of short chain sugars.
Benov, L; Fridovich, I, 1998
)
0.3
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
erythrose
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
Cori cycle121

Research

Studies (114)

TimeframeStudies, This Drug (%)All Drugs %
pre-199011 (9.65)18.7374
1990's10 (8.77)18.2507
2000's35 (30.70)29.6817
2010's40 (35.09)24.3611
2020's18 (15.79)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 67.86

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index67.86 (24.57)
Research Supply Index4.74 (2.92)
Research Growth Index4.89 (4.65)
Search Engine Demand Index112.33 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (67.86)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (0.88%)6.00%
Case Studies1 (0.88%)4.05%
Observational0 (0.00%)0.25%
Other112 (98.25%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]